Search Within

Katherine S Panageas

Formats
  1. Journal Article (320)
  2. Meeting Abstract (181)
  3. Editorial (5)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Review (4)
  7. Book Section (3)
  8. Miscellaneous (1)
Groups
  1. Biostatistics Service (523)
  2. Epidemiology and Biostatistics (523)
  3. Population Sciences Research Program (523)
  4. Department of Medicine (306)
  5. Solid Tumor Oncology Division (264)
  6. GSK Faculty (189)

More Groups

People
  1. Anne Reiner (94)
  2. Jedd Wolchok (92)
  3. Lisa De Angelis (86)
  4. Paul Chapman (77)
  5. Michael Postow (66)
  6. Clifford Hudis (56)

More People

Years
  1. 2025 (19)
  2. 2024 (23)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (34)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (109)
  2. Neuro-Oncology (42)
  3. Clinical Cancer Research (31)
  4. Annals of Surgical Oncology (28)
  5. Cancer (21)
  6. Breast Cancer Research and Treatment (20)

More Publications

Publishers
  1. American Society of Clinical Oncology (122)
  2. Oxford University Press (68)
  3. Springer (65)
  4. American Association for Cancer Research (56)
  5. Wiley Blackwell (38)
  6. American Medical Association (19)

More Publishers

Results (523)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Methotrexate (M) area under the curve (AUC) and creatinine clearance (CrCl) as prognostic factors in primary central nervous system lymphoma (PCNSL)
    Meeting Abstract

    Morris, P. G.; Abrey, L. E.; Reiner, A. S.; Panageas, K.; Seko, B.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A population-based study in acute promyelocytic leukemia (APL) suggests a higher early death rate and lower overall survival than commonly reported in clinical trials: Data from the Surveillance, Epidemiology, and End Results (SEER) program and the New York State Cancer Registry in the United States between 1992-2007
    Journal Article

    Park, J. H.; Panageas, K. S.; Schymura, M. J.; Qiao, B.; Jurcic, J. G.; Rosenblat, T. L.; Altman, J. K.; Douer, D.; Rowe, J. M.; Tallman, M. S.
    Blood (2010)

    Fulltext@MSK | Save
  • NY-ESO-1-specific CD8 T cell response in NY-ESO-1 seropositive metastatic melanoma patients treated with ipilimumab correlates with clinical benefit
    Meeting Abstract

    Yuan, J. D.; Gnjatic, S.; Adamow, M.; Ginsberg, B.; Rasalan, T. S.; Ritter, E.; Gallardo, H. F.; Xu, Y.; Pogoriler, E.; Panageas, K. S.; more...
    Journal of Immunotherapy (2010)

    Fulltext@MSK | Save
  • Predictors of morbidity of inguinal lymph node dissection in patients with melanoma
    Meeting Abstract

    Kingham, T.; Karakousis, G.; Panageas, K.; Ariyan, C. E.; Brady, M. S.; Coit, D. G.
    Annals of Surgical Oncology (2010)

    Fulltext@MSK | Save
  • Natural history of patients with stage III melanoma of unknown primary
    Meeting Abstract

    Karakousis, G. C.; Katz, S.; Panageas, K.; Ariyan, C.; Brady, M. S.; Coit, D.
    Annals of Surgical Oncology (2010)

    Fulltext@MSK | Save
  • Prognostic significance of pelvic nodal drainage (PLND) at sentinel lymph node (SLN) mapping for patients with extremity melanoma
    Meeting Abstract

    Karakousis, G. C.; Pandit-Taskar, N.; Atherton, S.; Hsu, M.; Panageas, K.; Ariyan, C.; Brady, M.
    Annals of Surgical Oncology (2010)

    Fulltext@MSK | Save
  • Cancer screening among patients with advanced cancer
    Journal Article

    Sima, C. S.; Panageas, K. S.; Schrag, D.
    JAMA - Journal of the American Medical Association (2010)

    Fulltext@MSK | Save
  • Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data
    Journal Article

    Sima, C. S.; Panageas, K. S.; Heller, G.; Schrag, D.
    Applied Health Economics and Health Policy (2010)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant temozolomide in resectable melanoma patients
    Journal Article

    Shah, G. D.; Socci, N. D.; Gold, J. S.; Wolchok, J. D.; Carvajal, R. D.; Panageas, K. S.; Viale, A.; Brady, M. S.; Coit, D. G.; Chapman, P. B.
    Annals of Oncology (2010)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save